Skip to main content

Top header menu

  • Access to EMARKET SDIR
  • English
  • Italian
Home
EMARKET STORAGE - Teleborsa

Navigazione principale

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are
Menu

ALL Regulated Press Releases

Home Regulated Press releases
05/13/2020 - 13:11
DIASORIN
Risultati DiaSorin - Q1 2020
05/11/2020 - 19:59
DIASORIN
DiaSorin S.p.A. - Shareholders' Meeting June 10, 2020 - Notice to call
05/11/2020 - 19:57
DIASORIN
DiaSorin S.p.A. - Assemblea degli Azionisti 10 giugno 2020 - Avviso di convocazione
05/08/2020 - 19:32
DIASORIN
Notice re: Annual Report
05/08/2020 - 19:31
DIASORIN
Avviso Relazione Finanziaria Annuale
04/29/2020 - 18:30
DIASORIN
Notice of availability Annual Report
04/29/2020 - 18:28
DIASORIN
Avviso disponibilita' Relazione Finanziaria Annuale
04/25/2020 - 16:30
DIASORIN
DiaSorin - FDA EUA and BARDA funding for SARS-CoV-2 IgG
04/25/2020 - 16:28
DIASORIN
DiaSorin riceve l'EUA dalla FDA americana sul test LIAISON® SARS-COV-2 S1/S2 IGG
04/22/2020 - 20:34
DIASORIN
Comunicato Internal Dealing
04/22/2020 - 15:49
DIASORIN
Comunicato Internal Dealing
04/22/2020 - 15:45
DIASORIN
Comunicato Internal Dealing
04/17/2020 - 18:22
DIASORIN
DIASORIN HAS CE MARKED ITS SARS-COV-2 IGG SEROLOGY KIT FOR COVID-19
04/17/2020 - 18:21
DIASORIN
DIASORIN HA MARCATO CE IL PROPRIO TEST SIEROLOGICO SARS-COV-2 IGG PER IL COVID-19
04/16/2020 - 15:14
DIASORIN
Comunicato Internal Dealing
04/07/2020 - 07:10
DIASORIN
Launch of IgG test to detect immune response to SARS-COV-2
04/07/2020 - 07:09
DIASORIN
Lancio test IgG per identificare risposta immunitaria al SARS-COV-2
03/26/2020 - 18:14
DIASORIN
Update Annual Calendar of Corporate Events 2020
03/26/2020 - 18:12
DIASORIN
Aggiornamento Calendario Annuale Eventi Societari 2020
03/21/2020 - 20:22
DIASORIN
DiaSorin S.p.A. Shareholders' Meeting date change
03/21/2020 - 20:20
DIASORIN
Variazione data Assemblea degli Azionisti DiaSorin S.p.A.
03/20/2020 - 07:26
DIASORIN
DIASORIN COVID-19 TEST HAS RECEIVED FDA EMERGENCY USE AUTHORIZATION
03/20/2020 - 07:25
DIASORIN
DIASORIN - APPROVAZIONE FDA EUA TEST COVID-19 NEGLI USA
03/13/2020 - 17:13
DIASORIN
DiaSorin received BARDA funding to develop a rapid COVID-19 test

Pagination

  • First page « First
  • Previous page ‹ Precedente
  • …
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Current page 18
  • Page 19
  • Page 20
  • Page 21
  • Next page Seguente ›
  • Last page Last »

Footer menu

  • Disclaimer
  • Privacy
  • Cookies
  • Emergency assistance

Teleborsa - Logo

©Copyright 2022 Teleborsa S.r.l. No material on this site may be published, distributed, sold or reproduced in any form, whether printed or written, without the authorization of Teleborsa S.r.l.

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are